These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30104156)

  • 21. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
    Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
    J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
    Schrag D; Cramer LD; Bach PB; Begg CB
    J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
    Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
    J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
    Iwashyna TJ; Lamont EB
    J Clin Oncol; 2002 Oct; 20(19):3992-8. PubMed ID: 12351596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data.
    Raab GT; Lin A; Hillyer GC; Keller D; O'Neil DS; Accordino MK; Buono DL; Hur C; Kiran RP; Wright JD; Hershman DL; Neugut AI
    Clin Colorectal Cancer; 2019 Sep; 18(3):e294-e299. PubMed ID: 31266707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer.
    Hu CY; Delclos GL; Chan W; Du XL
    Med Oncol; 2011 Dec; 28(4):1062-74. PubMed ID: 20714945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
    Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
    J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
    Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
    Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
    van Steenbergen LN; Lemmens VEPP; Rutten HJT; Wymenga ANM; Nortier JWR; Janssen-Heijnen MLG
    Ann Oncol; 2012 Nov; 23(11):2805-2811. PubMed ID: 22562836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
    Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
    Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Medicare Claims-based Proxy Measures of Poor Function and Associations With Treatment Receipt and Mortality in Older Colon Cancer Patients.
    Mayer SE; Tan HJ; Peacock Hinton S; Sanoff HK; Stürmer T; Hester LL; Faurot KR; Jonsson Funk M; Lund JL
    Med Care; 2019 Apr; 57(4):286-294. PubMed ID: 30789540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN
    BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
    Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.
    Jiao X; Hay JW; Sadeghi S; Barzi A
    Am J Clin Oncol; 2020 Jun; 43(6):428-434. PubMed ID: 32187027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
    Sundararajan V; Mitra N; Jacobson JS; Grann VR; Heitjan DF; Neugut AI
    Ann Intern Med; 2002 Mar; 136(5):349-57. PubMed ID: 11874307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
    Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
    Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
    Gross CP; McAvay GJ; Guo Z; Tinetti ME
    Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.